Volume 0 - Int J Mol Cell Med (Inprees)                   Int J Mol Cell Med 2025, 0 - Int J Mol Cell Med (Inprees): 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khoshkholgh Pahlaviani M R M, Emami A, Mahmoodi S M M, Rezaeian A A. Evaluation of properties of Lactobacillus delbrueckii as an antitumor agent: effects in cell cycle, apoptosis, and gene expression in HT-29 colorectal cancer cells. Int J Mol Cell Med 2025;
URL: http://ijmcmed.org/article-1-2558-en.html
1- Department of Microbiology, La.C, Islamic Azad University, Lahijan, Iran.
2- Burn & Wound Healing Research Center, Shi.C, Shiraz, Iran.
3- Department of Microbiology, Kaz.C, Islamic Azad University, Kazerun, Iran.
4- Department of Microbiology, Ja.C, Islamic Azad University, Jahrom, Iran. , AA.Rezaeian@iau.ac.ir
Abstract:   (2 Views)
This study investigated the anti-tumor properties of Lactobacillus delbrueckii, a probiotic bacterium, against HT-29 human colorectal cancer cells.
The primary objective was to evaluate the effects of Lactobacillus delbrueckii supernatant on gene expression, cell viability, apoptosis, and cell cycle progression in HT-29 cells. In Gilan Province, Iran, a native strain of Lactobacillus delbrueckii was identified from the supernatant of local yogurt. After treating HT-29 cells with different doses of the supernatant, the MTT test was used to calculate the IC50 value 24 hours later. Annexin V/PI staining and flow cytometry were used to evaluate the induction of apoptosis, and real-time PCR was used to measure changes in gene expression. The results showed that the supernatant of Lactobacillus delbrueckii strongly and dose-dependently reduced the growth of HT-29 cells. In addition to causing apoptosis and stopping the cell cycle in the G0/G1 phase, the therapy also increased the number of Sub-G1 cells, which is a sign of cell death. According to gene expression study, anti-apoptotic genes (AKT, Bcl-2) were downregulated while pro-apoptotic genes (PTEN, p53, and Bax) were upregulated. Interestingly, the natural isolate outperformed a conventional strain in terms of anticancer efficacy. These results demonstrate Lactobacillus delbrueckii's potential as a colorectal cancer treatment.
Full-Text [PDF 861 kb]   (1 Downloads)    
Type of Study: Original Article | Subject: Cancer
Received: 2025/02/28 | Accepted: 2025/07/8 | Published: 2025/07/28

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | International Journal of Molecular and Cellular Medicine IJMCM

Designed & Developed by : Yektaweb